U-Blot® Research Grade Anti-Human CD20/MS4A1 (KN001)Cat. No. WA1396Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD20/MS4A1 (KN001)Cat. No. WA1396
U-Blot® Research Grade Anti-Human CD20/MS4A1 (GNR-006)Cat. No. WA1395
U-Blot® Research Grade Anti-Human CD20/MS4A1 (EDC9)Cat. No. WA1394
U-Blot® Research Grade Anti-Human CD20/MS4A1 (DXLr120)Cat. No. WA1393
U-Blot® Research Grade Anti-Human CD20/MS4A1 (DXL625)Cat. No. WA1392
U-Blot® Research Grade Anti-Human CD20/MS4A1 (CHO-H01)Cat. No. WA1391
U-Blot® Research Grade Anti-Human CD20/MS4A1 (BVX20)Cat. No. WA1390
U-Blot® Research Grade Anti-Human CD20/MS4A1 (BLX-301)Cat. No. WA1389
U-Blot® Research Grade Anti-Human CD20/MS4A1 (BAT 4406F)Cat. No. WA1388
U-Blot® Research Grade Anti-Human CD20/MS4A1 (BAT 4306F)Cat. No. WA1387
U-Blot® Research Grade Anti-Human CD2 (BTI-322)Cat. No. WA1386
U-Blot® Research Grade Anti-Human CD198/CCR8 Antibody (S-531011)Cat. No. WA1385